Follow the 우정바이오 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 우정바이오 has logged 71 insider filings. Market capitalisation: €37.9bn. The latest transaction was disclosed on 4 June 2026 (Purchase). Among the most active insiders: 수성자산운용. The full history is openly available.
71
Insider Decl.
n/a
Thresholds
€12,441
19 ops.
Buy Volume
n/a
39 ops.
Sell Volume
22Σ signal
Buys €12,441n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,310 of 29,064 companies
21.3
score / 100
Value
21
Quality
21
FCF yld-2.4%
Earn yld-15%
EV/EBITDA·
ROE-15%
Gross mgn27%
Net mgn-15%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.